Log In
BCIQ
Print this Print this
 

TV-1380

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionRecombinant human serum albumin (HSA) mutated butyrylcholinesterase (AlbuBChE)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationAddiction
Indication DetailsTreat cocaine addiction
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today